May 2026 Issues of APA Journals Feature New Research on PTSD, Substance Use Disorders, Psychopharmacologic Treatments, and More
Washington, D.C. — The latest issues of three American Psychiatric Association journals (The American Journal of Psychiatry, Psychiatric Services, and Focus) are now available online.
The American Journal of Psychiatry
The May issue of The American Journal of Psychiatry brings together research that furthers the understanding of PTSD and substance use disorders. Highlights of the issue include:
- Resting-State Functional Connectivity of the Amygdala and Hippocampus in PTSD (AJP Deputy Editor Daniel Pine, M.D., highlights the study in this video).
- Personalized fMRI-Guided TMS Targeting the Threat Neurocircuitry in PTSD: A Randomized Clinical Trial. (AJP Deputy Editor Pine highlights the study in this video.)
- How a large national community clinic data set was used to find sex differences in comorbid psychiatric conditions among individuals with opioid, alcohol, and cannabis use disorders. (Lead author Eduardo Butelman is the guest on May's AJP Audio podcast episode.)
Also in this issue, five commentaries discuss the future of the Diagnostic and Statistical Manual of Mental Disorders (DSM). Read more: APA Releases Roadmap for the Future of the DSM.
Psychiatric Services
- The Executive Order on “Crime and Disorder”: An Affront to Policy, Law, and Ethics
- Characteristics of Studies on the Diagnosis of Malingering: A Systematic Review
- Quality of Lethal Means Counseling Documentation in the Veterans Health Administration
- Individual Placement and Support and Long-Term Employment: A Review of Long-Term Follow-Up Studies
- Suicide Risk and Health Care Utilization Among Veterans Contacting the Veterans Crisis Line: Retrospective Cohort Study
Focus: The Journal of Lifelong Learning in Psychiatry
Led by guest editors Venkat Bhat, M.D., M.Sc., of St. Michael’s Hospital and University of Toronto, and Manish K. Jha, M.D., of UT Southwestern Medical Center, the current issue of Focus explores new insights in psychopharmacologic treatments and offers expert perspectives on their clinical applications across psychiatric disorders.
- Emerging Clinical Applications of Ketamine and Esketamine Across Psychiatric Disorders
- Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications
- Anabolic Androgenic Steroids: Emerging Use Disorder, Mechanisms of Action, and Clinical Considerations for Pharmacotherapy
- Psychopharmacology and Neurocognitive Disorders: Evidence for Cognitive and Behavioral Symptom Management
Journalists who wish to access the publications should email [email protected].
American Psychiatric Association
The American Psychiatric Association, founded in 1844, is the oldest medical association in the country. The APA is also the largest psychiatric association in the world with more than 40,400 physician members specializing in the diagnosis, treatment, prevention, and research of mental illnesses. APA’s vision is to ensure access to quality psychiatric diagnosis and treatment. For more information, please visit www.psychiatry.org.